Search Results - "Fra, J"

Fotemustine Compared With Dacarbazine in Patients With Disseminated Malignant Melanoma: A Phase III Study by AVRIL, M. F, AAMDAL, S, PORTA, V. Guillem, FRA, J, BONNETERRE, J, SAÏAG, P, KAMANABROU, D, PEHAMBERGER, H, SUFLIARSKY, J, GONZALEZ LARRIBA, J. L, SCHERRER, A, MENU, Y, GROB, J. J, HAUSCHILD, A, MOHR, P, BONERANDI, J. J, WEICHENTHAL, M, NEUBER, K, BIEBER, T, GILDE, K

“…To compare fotemustine and dacarbazine (DTIC) in terms of overall response rate (ORR) as primary end-point and overall survival, duration of responses, time to…”
Get full text

Long-term biomonitoring of breast cancer patients under adjuvant chemotherapy: the comet assay as a possible predictive factor by Uriol, E, Sierra, M, Comendador, M A, Fra, J, Martínez-Camblor, P, Lacave, A J, Sierra, L M

“…Most chemotherapy treatments induce DNA damage in the exposed patients. Using the comet assay and peripheral blood mononuclear cells (PBMC), we have quantified…”
Get full text

4CPS-105 Cardiovascular risk factors in patients with HIV infection with antiretroviral treatment by Fernández González, A, Aparicio Carreño, C, Gándara Ande, A, Fórneas Sangil, A, Fuertes Camporro, S, Fra Yañez, J

“…Background and importanceCardiovascular disease (CVD) is a major cause of morbidity and mortality in HIV patients. Recent studies suggest that the increased…”
Get full text

Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy by Esteban, E., González de Sande, L., Fernández, Y., Corral, N., Fra, J, Muñiz, I., Vieitez, J. M., Palacio, I., Fernández, J. L., Estrada, E., Lacave, A. J.

“…Background: Docetaxel and paclitaxel have activity in the second-line treatment of non-small-cell lung cancer (NSCLC), and can be administered as weekly…”
Get full text

4CPS-115 Rituximab in the treatment of primary glomerulonephritis by Lamas Lopez, M, Orallo Luna, C, Fra Yañez, J, Becerra Injerto, L, Fernández González, A, González Sánchez, N, Puente Martínez, P

“…BackgroundPrimary glomerulonephritis is usually treated with steroids and immunosuppressants, however, some patients exhibit treatment resistance or severe…”
Get full text

4CPS-092 Prevalence of polypharmacy in patients with human immunodeficiency virus infection by Orallo Luna, C, Fra Yáñez, J, Becerra Ingerto, L, Gómez de Segura Iiriarte, L, González Sánchez, N, Puente Martín, P, Lamas Lopez, M

“…BackgroundDue to the introduction of highly active antiretroviral therapy (HAART), the percentage of older HIV-positive patients is growing, with an increase…”
Get full text

Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomas by LOSA, R, FRA, J, ESCUDERO, P, ESTEBAN, E, BUESA, José M, LOPEZ-POUSA, A, SIERRA, M, GOITIA, A, UNA, E, NADAL, R, GARCIA DEL MURO, J, GION, M, MAUREL, J

“…Based on the promising results of a Phase I study with a combination of gemcitabine and DTIC performed in advanced soft tissue sarcoma (ASTS) patients, and due…”
Get full text

2222P Frequent TERT gains in metastatic papillary thyroid carcinoma by Gil, S., Corraliza, M., Feas-Rodriguez, N., Herguedas-Sanz, J., Fra, J., García - Rostán, G.M.

Get full text

Panhipopituitarismo secundario a metástasis hipofisaria en una paciente con cáncer de mama by Gil, J, Crespo, C, Fra, J, Ruiz de Temiño, Á, Cuéllar, L

Get full text

1755P A comprehensive study of the role of EIF1AX mutations in anaplastic thyroid carcinomas. Relationship with established mutational events, tumor progression and dedifferentiation by Bernabé, S. Gil, Feas, N., De Pablo, S. Minguela, Rodríguez, J. Fra, García-Rostán, G.

Get full text

Phase I II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study by LOPEZ-POUSA, A, LOSA, R, MARTINEZ-TRUFERO, J, ESTEBAN, E, BUESA, J. M, MARTIN, J, MAUREL, J, FRA, J, SIERRA, M, CASADO, A, GARCIA DEL MURO, J, POVEDA, A, BALANA, C

“…The aim of the study was to determine the dose-limiting toxicity and maximum tolerated dose of a first-line combination of doxorubicin and gemcitabine in adult…”
Get full text

20P Distinctive genomic profile of lymph node profile and distant metastasis in papillary thyroid cancer by Gil-Bernabé, S., Feas-Rodriguez, N., Corraliza, M., Costa, A.M., Rodriguez, J. Fra, García - Rostán, G.M.

Get full text

Dopamine and migraine: a review of pharmacological, biochemical, neurophysiological, and therapeutic data by Mascia, A, Afra, J, Schoenen, J

“…The dopamine theory of migraine pathogenesis, first proposed by F. Sicuteri in 1977, has attracted renewed interest after an increased frequency of the…”
Get more information

1159P Characterization of melanoma of unknown primary in the era of immunotherapy and targeted therapy in Spain: Results from the prospective real-world study GEM 1801 by Cerezuela-Fuentes, P., Piñero-Madrona, A., Muñoz-Couselo, E., Manzano, J.L., Berciano-Guerrero, M-Á., Majem, M., Espinosa, E., Soria, A., Ayala de Miguel, P., García Castaño, A., Crespo, G., Gutiérrez Sanz, L., Aguado de la Rosa, C., Fernández-Morales, L.A., Puértolas, T., Fra, J., Rodríguez de la Borbolla, M., Bellido, L., Martín Algarra, S., Márquez-Rodas, I.

Get full text

EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias by May, A., Leone, M., Áfra, J., Linde, M., Sándor, P. S., Evers, S., Goadsby, P. J.

“…Cluster headache and the other trigeminal‐autonomic cephalalgias [paroxysmal hemicrania, short‐lasting unilateral neuralgiform headache attacks with…”
Get full text

A phase II trial of cyclophosphamide, epirubicin and vinorelbine in the treatment of advanced breast cancer by ESTEBAN, E, DE SANDE, Gonzalez, SALA, M, LACAVE, A. J, PUERTAS, J, FRA, J, PALACIO, I, VIEITEZ, J. M, FERNANDEZ, J. L, MUNIZ, I, MODOLLEL, A, CARRASCO, J

“…Vinorelbine (Navelbin; N) has proven to be active in patients with advanced breast cancer (ABC) and cyclophosphamide (C) and epirubicin (Epiadriamycin: E) are…”
Get full text

Phase II trial of epirubicin at standard dose in relapsed ovarian cancer by Peláez, I., Lacave, A.J., Palacio, I., Alvarez, E., Cueva, J.F., Muñiz, I., Arranz, F., Fra, J.

Get full text

Activity of doxorubicin after high-dose ifosfamide in adult patients with advanced soft tissue sarcoma: A study of the Spanish Group for Research on Sarcomas (GEIS) by Buesa, J. M., Fra, J., Antón, A., López-Pousa, A., Martín, J., García del Muro, J., Escudero, P., Casado, A., Poveda, A.

Get full text

227PPROGNOSIS OF PHOSPHORYLATED-INSULIN GROWTH FACTOR RECEPTOR (P-IGF-1R) AND METALLOPROTEINASE-3 (MMP3) EXPRESSION IN ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) PATIENTS TREATED WITH IMATINIB. A GEIS STUDY by Maurel, J., Lopez-Pousa, A., Calabuig, S., Bagué, S., Del Muro, X. García, Sanjuan, X., Rubió, J., Cuatrecasas, M., Martinez-Trufero, J., Horndler, C., Fra, J., Morales, C. Valverde, Redondo, A., Poveda, A.M., Sevilla, I., Lainez, N., Rubini, M., Albéniz, X. García, Broto, J. Martin, De Álava, E.

“…Abstract Aim: Most GISTs have mutations in KIT or PDGFRA. Patients with advanced GIST with KIT exon 9, with PDGFRA mutation or WT for KIT and PDGFRA have a…”
Get full text

Prognosis of Phosphorylated-Insulin Growth Factor Receptor (P-Igf-1R) and Metalloproteinase-3 (Mmp3) Expression in Advanced Gastrointestinal Stromal Tumors (Gist) Patients Treated with Imatinib. a Geis Study by Maurel, J., Lopez-Pousa, A., Calabuig, S., Bagué, S., Del Muro, X. García, Sanjuan, X., Rubió, J., Cuatrecasas, M., Martinez-Trufero, J., Horndler, C., Fra, J., Morales, C. Valverde, Redondo, A., Poveda, A.M., Sevilla, I., Lainez, N., Rubini, M., Albéniz, X. García, Broto, J. Martin, De Álava, E.

Get full text